Page 10 - Institut Pasteur News Today

In collaboration with 12 partners from 6 countries, MatTek is establishing the Antivirus Pandemic Preparedness EuropeAn pLatform (APPEAL), a European research initiative aimed at enhancing preparedness for future pandemics.

Starting treatment early may promote long-term control of the HIV virus if treatment is not discontinued, finds a study.People living with HIV need to take antiretroviral treatment for life to prevent the virus from multiplying in their body. ...

Contact: Press presse@inserm.fr INSERM (Institut national de la santé et de la recherche médicale) By demonstrating that it is possible to inhibit the viral infection in vitro by blocking the bonding between the virus and these receptors, the researchers have opened the way to a new antiviral strategy. These works were published on line in…

Sensorion announced today that it has received approval for its Phase 1/2 clinical trial for SENS-501 , its most advanced gene therapy candidate for hearing disorders. The SENS-501 gene therapy...

Experts say its mutations mean it can infect lung cells more easily but that it is also less contagious

Experts say its mutations mean it can infect lung cells more easily but that it is also less contagious

It is time for Africa to focus on producing vaccines for its population.

It is time for Africa to focus on producing vaccines for its population

DNA fragments from thousands of years ago are providing insights into multiple sclerosis, diabetes, schizophrenia and other illnesses.

Recent approval by the Vaccine Alliance (Gavi) of a US$1.8 billion African Vaccine Manufacturing Accelerator (AVMA), a financing instrument that will support sustainable vaccine manufacturing in Africa is being hailed as a  game changer for the continent.